ArticleSubstance abuse2022

Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies.

Traci C Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.